NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

疫苗物流的全球市場- 成長,趨勢,COVID-19的影響,及預測(2021年∼2026年)

Vaccine Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 1008487
出版日期 內容資訊 英文 200 Pages
商品交期: 2-3個工作天內
價格
疫苗物流的全球市場- 成長,趨勢,COVID-19的影響,及預測(2021年∼2026年) Vaccine Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
出版日期: 2021年05月13日內容資訊: 英文 200 Pages
簡介

疫苗物流的市場規模由於COVID-19疫情影響,在2021年∼2025年間的預測期間內預計將以指數函數性地擴大。

種類繁多的新疫苗和免疫計劃、多樣化的服務提供策略、更多的人口以及增加的冷鏈基礎設施需求是影響疫苗物流市場的因素。市場的驅動力是解決現有系統無法解決的問題(缺貨、可避免的消費和浪費、冷鏈能力不足),尤其是在開發 COVID-19 疫苗之後。

本報告提供疫苗物流市場調查,提供市場概要,市場成長要素及阻礙因素分析,各類服務·各終端用戶·各地區的分析,競爭情形,再加上主要企業的簡介等全面性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態和市場洞察

  • 目前市場方案
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 技術趨勢與自動化
  • 政府的法規與措施
  • 產業價值鏈·供應鏈分析
  • 聚焦環境溫度/溫控存儲
  • 產業的魅力- 波特的五力分析
  • COVID-19對市場的影響

第5章 市場區隔

  • 各類服務
    • 交通途徑
    • 倉儲業
    • 附加價值服務(包裝,標籤等)
  • 各終端用戶
    • 醫院
    • 醫藥品製造經銷商
    • 其他終端用戶(血液銀行,診所等)
  • 各地區
    • 亞太地區
    • 歐洲
    • 北美
    • 南美
    • 中東

第6章 競爭情形

  • 市場集中概要
  • 企業簡介
    • DHL Global Forwarding
    • AllCargo Logistics
    • American Airlines
    • DB Schenker
    • FedEx Corporation
    • Kuehne Nagel
    • Nippon Express
    • Yamato Logistics
    • Americold Logistics
    • Cavalier Logistics*
  • 其他公司

第7章 全球LOGISTICS疫苗市場未來

第8章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 72034

With the ongoing COVID-19 pandemic, the demand for vaccine logistics is expected to increase exponentially during the forecast period. A widening variety of new vaccines and immunization schedules, a diversity of service delivery strategies, expanding target population, increased cold-chain infrastructure requirements and insufficient funding, are just a few of the new realities that will further impact the vaccine transportation market.

Existing systems are struggling to keep pace with the changing landscape of national and international immunization programmes, especially post the development of the COVID-19 vaccine, resulting in stock-outs, avoidable wastage and inadequate cold-chain capacity, all of which have considerable coverage, performance and cost implications.

Cold chain logistics companies and several other companies are focusing on the development and deployment of advanced technologies to aid the transportation of the COVID-19 vaccines ensuring their capacity and reach to challenging places across the world making the vaccine available to all without any loss during the transition.

Key Market Trends

Growth in the Pharmaceutical sector

With government initiatives to improve the pharmaceutical industry growth across the world and fuel competition within the market, the demand for pharma logistics will increase globally. As strong growth continues across the global pharmaceuticals industry, the sub-category of temperature-controlled products is surging ahead. Pharmaceutical manufacturers across the world are increasingly focusing on product quality and sensitivity. Factors, such as the development of complex biological-based medicines and shipments of hormone treatments, vaccines, and complex proteins, which require cold chain refinements, result in the need for temperature-controlled transportation and warehousing.

Temperature-controlled logistics of pharmaceutical products and medical devices is a significantly growing part of the healthcare logistics industry. Moreover, the increase in the need for effective cold chain logistics services to maintain the quality of goods is fueling the growth of the market.

The rising importance of fast-track assistance in the healthcare sector is also driving the market for pharmaceutical logistics. Moreover, decreasing the distribution cost by creating a single source distribution channel is further boosting the demand for pharmaceutical logistics.

Boost in the market aided by the development in cold chain logistics

Thermal stability is not a property of most vaccines, including the ones used against diphtheria, tetanus and pertussis (DTP), and measles, mumps and rubella (MMR). Normally, vaccines that are not heat-stable and which aren't properly refrigerated spoil over a short period of time, because they contain biological matter that degrades when not stored between 2°C and 8°C. As a result, the majority of vaccines rely on refrigerated or "cold chain" distribution, which consists of several stages.

The refrigerated trucks that can hold goods in multiple segments at different temperatures are developed and are gaining popularity. The cold chain service providers are also installing RFID (Radio-frequency identification) and IIoT (Industrial Internet of things) to help to address cold chain inefficiencies by providing increased insights into locations, properties, and conditions of sensitive products.

Companies are also developing high-tech containers specially designed to serve the pharmaceutical industry with a closed temperature-controlled system for seamless delivery of temperature-sensitive goods between cargo warehouses and aircraft. dnata's (a pharma logistics provider) new equipment, as reported in October 2020, allows the company to transport temperature-sensitive cargo to the highest international standards. Providing temperature-controlled storage from -18°C up to +25°C, the cool dollies mitigate risk of temperature deviations and contamination.

Competitive Landscape

The global vaccine logistics market is fragmented in nature and is considerably dominated by various international companies such as Yamato, Deutsche Post DHL Group, Nippon Express. The strong presence of international companies across the globe have been helping them to expand more into the market with much more ease and are focusing on expansion strategies through acquisitions.

With the COVID-19 pandemic, the market is expected to experience an increased demand for refrigerated warehouses, fast and controlled delivery services and bulk transportation of vaccines backed by the increasing government investment providing opportunities to the players in the market to expand their reach and efficiency in the long run.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS AND INSIGHTS

  • 4.1 Current Market Scenario
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Technological Trends and Automation
  • 4.4 Government Regulations and Initiatives
  • 4.5 Industry Value Chain/Supply Chain Analysis
  • 4.6 Spotlight on Ambient/Temperature-controlled Storage
  • 4.7 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.8 Impact of COVID-19 on the Market

5 MARKET SEGMENTATION

  • 5.1 By Service
    • 5.1.1 Transportation
      • 5.1.1.1 Land (Road & Rail)
      • 5.1.1.2 Air
      • 5.1.1.3 Sea
    • 5.1.2 Warehousing
    • 5.1.3 Value-Added Services (packaging, labelling, etc.)
  • 5.2 By End-Users
    • 5.2.1 Hospitals
    • 5.2.2 Drugs manufacturers and distributors
    • 5.2.3 Other end-users (blood banks, clinics, etc.)
  • 5.3 By Geography
    • 5.3.1 Asia Pacific
      • 5.3.1.1 China
      • 5.3.1.2 Japan
      • 5.3.1.3 Australia
      • 5.3.1.4 India
      • 5.3.1.5 Singapore
      • 5.3.1.6 Malaysia
      • 5.3.1.7 Indonesia
      • 5.3.1.8 Thailand
      • 5.3.1.9 South Korea
      • 5.3.1.10 Rest of Asia-Pacific
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 France
      • 5.3.2.3 United Kingdom
      • 5.3.2.4 Italy
      • 5.3.2.5 Rest of Europe
    • 5.3.3 North America
      • 5.3.3.1 United States
      • 5.3.3.2 Canada
      • 5.3.3.3 Mexico
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Colombia
      • 5.3.4.3 Argentina
      • 5.3.4.4 Rest of South America
    • 5.3.5 Middle East
      • 5.3.5.1 Egypt
      • 5.3.5.2 Qatar
      • 5.3.5.3 Saudi Arabia
      • 5.3.5.4 United Arab Emirates
      • 5.3.5.5 South Africa
      • 5.3.5.6 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration Overview
  • 6.2 Company Profiles
    • 6.2.1 DHL Global Forwarding
    • 6.2.2 AllCargo Logistics
    • 6.2.3 American Airlines
    • 6.2.4 DB Schenker
    • 6.2.5 FedEx Corporation
    • 6.2.6 Kuehne Nagel
    • 6.2.7 Nippon Express
    • 6.2.8 Yamato Logistics
    • 6.2.9 Americold Logistics
    • 6.2.10 Cavalier Logistics*
  • 6.3 Other Companies

7 FUTURE OF GLOBAL VACCINE LOGISTICS MARKET

8 APPENDIX